Table 1. Comparison of the clinical characteristics of GDM and healthy pregnant women.
| Characteristics | Non-GDM (n = 289) | GDM (n = 111) | P |
|---|---|---|---|
| Age (years) | 29.60±3.78 | 31.34±3.71 | <0.01** |
| BMI (kg/m2) | 24.17±3.64 | 25.36±3.56 | 0.004** |
| SP (mmHg) | 111.07±13.91 | 116.15±16.88 | 0.012* |
| DP (mmHg) | 66.39±9.27 | 68.98±11.01 | 0.034* |
| FPG(mmol/L) | 4.39±0.33 | 4.80±0.61 | <0.01** |
| 60-min PG(mmol/L) | 8.03±1.13 | 9.99±1.41 | <0.01** |
| 120-min PG(mmol/L) | 6.45±1.18 | 8.62±1.56 | <0.01** |
| HbA1c (%) | 4.95(4.8–5.2) | 5.20(4.9–5.45) | <0.01** |
| BUN (mmol/L) | 2.64±0.63 | 2.67±0.64 | 0.693 |
| Cr (mmol/L) | 42.92±5.37 | 43.65±6.29 | 0.267 |
| UA (mmol/L) | 201.26±40.59 | 219.21±61.18 | 0.007** |
| CysC (mg/L) | 0.70(0.6–1.0) | 1.0(0.8–1.8) | <0.01** |
| TC (mmol/L) | 5.05±0.93 | 5.25±1.08 | 0.086 |
| TG (mmol/L) | 1.49(1.10–2.02) | 1.79(1.32–2.49) | 0.003** |
| HDL-C (mmol/L) | 1.81±0.35 | 1.80±0.34 | 0.859 |
| LDL-C (mmol/L) | 2.55±0.68 | 2.60±0.72 | 0.492 |
| ALT (U/L) | 17(11–24) | 14(10–23) | 0.203 |
| AST (U/L) | 19(15–23.25) | 18(15–24) | 0.645 |
| GGT (U/L) | 14(11–17) | 13(10–21) | 0.263 |
| HOMA-IR | 1.41(0.96–2.05) | 2.10(1.44–2.93) | <0.01** |
| HOMA-%β | 170.76(119.14–259.28) | 167.37(111.04–239.24) | 0.567 |
Data are expressed as means ± SD or median (25th-75thpercentiles).
* P<0.05 compared with the non-GDM group.
** P<0.01 compared with the non-GDM group.
GDM: gestational diabetes mellitus; BMI: body mass index; SP: systolic pressure; DP: diastolic pressure; FPG: fasting plasma glucose; HbA1c: glycosylatedhemoglobin; BUN: blood urea nitrogen; Cr: serum creatinine; UA: uric acid; CysC: Cystatin C; TC: total cholesterol; TG: triglyceride; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; AST: aspartate aminotransferase; ALT: alanine aminotransferase; GGT: gamma-glutamyltranspeptidase; HOMA-IR: homeostasis model assessment of insulin resistance index; HOMA-%β: homeostasis model assessment of β-cell insulin secretion